z-logo
open-access-imgOpen Access
Phenotypic and Genotypic Characterization of Pyrazinamide Resistance among Multidrug-Resistant Mycobacterium tuberculosis Isolates in Zhejiang, China
Author(s) -
Qiang Xia,
Lili Zhao,
Feng Li,
Yumei Fan,
Yuanyuan Chen,
Beibei Wu,
Zhengwei Liu,
Aizhen Pan,
Min Zhu
Publication year - 2015
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.04541-14
Subject(s) - pyrazinamide , mycobacterium tuberculosis , biology , genotype , drug resistance , multiple drug resistance , microbiology and biotechnology , tuberculosis , streptomycin , genetics , virology , gene , medicine , rifampicin , antibiotics , pathology
To explore the phenotypic and genotypic characterization of pyrazinamide (PZA) resistance among multidrug-resistantMycobacterium tuberculosis (MDR-TB) isolates in Zhejiang province, a total of 274 MDR-TB isolates were collected. Drug susceptibility testing and spoligotyping were performed on all clinical isolates. In addition, the mutated features of PZA-resistant loci, includingpncA andrpsA , were also analyzed by DNA sequencing. Our results showed that the prevalence of PZA resistance among MDR-TB strains in Zhejiang province was 43.07% and that PZA resistance was associated with concomitant resistance to streptomycin. The majority of PZA-resistant MDR-TB isolates belonged to the Beijing family. Mutations withinpncA , notrpsA , constituted the primary mechanism of PZA resistance. Among 118 PZA-resistant isolates, 53 different mutations were observed inpncA , and most of them were point mutations. Compared with the phenotypic data, DNA sequencing ofpncA has sensitivity and specificity of 77.97% and 96.79%, respectively. Analysis ofpncA provided a robust tool for rapid detection of PZA drug resistance.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom